JAMP OLOPATADINE 0.2% DIN 02560976
Health Canada record
| Active ingredient(s) | OLOPATADINE HYDROCHLORIDE 0.2 % |
|---|---|
| Dosage form | Solution |
| Route | Ophthalmic |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | S01GX09 OLOPATADINE |
| Original market date | |
| Current status date | 10-Sep-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing OLOPATADINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02564769 | AG-OLOPATADINE 0.2% | ANGITA PHARMA INC. | Solution | OLOPATADINE HYDROCHLORIDE 0.2 % | Approved |
| 02531186 | RYALTRIS | GLENMARK SPECIALTY SA | Spray (Metered-Dose) | OLOPATADINE HYDROCHLORIDE 665 MCG; MOMETASONE FUROATE (MOMETASONE FUROATE MONOHYDRATE) 25 MCG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 35984 | 2025-09-10 | Abbreviated New Drug Submission (ANDS) |
International API supply for OLOPATADINE HYDROCHLORIDE
10 active FDA Drug Master Files.
Request a quote for JAMP OLOPATADINE 0.2%